feed,title,long_url,short_url
Benzinga,"Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate",https://benzinga.com/general/biotech/24/05/38607066/amgen-stock-adds-good-weight-after-ceos-update-on-experimental-drug-rivaling-ozempic-nixing-oral-,https://da.gd/uGZRYd
